June 7 “Urgent Profit Alert” from “Most Profitable Calendar”

by Travis Johnson, Stock Gumshoe | May 20, 2014 4:00 pm

Bonus look at a teaser alert for the Irregulars

This is premium content. To view this article (and to have full access to the rest of our articles), sign up. Already a member? Log in.

Source URL: https://www.stockgumshoe.com/reviews/bioscience-millionaire/june-7-urgent-profit-alert-from-most-profitable-calendar/


17 responses to “June 7 “Urgent Profit Alert” from “Most Profitable Calendar””

  1. DrKSSMDPhD says:

    Travis, Zerenix is a phosphate binder for people in renal failure on dialysis. The kidney normally clears excessive phosphate into urine. Renal failure patients get hyperphosphatemic, which, because phosphate binds calcium, causes calcium to nosedive. But frankly, this new agent adds little to the field. I have known this date was coming but deliberately did not mention it to the biotech irregulars because it is a non-event for a savvy investor.

  2. hedy1234 says:

    No place to subscribe.

  3. vivianlewis says:

    SG stands for stock gumshoe of course. I am not sure about the feather.
    the stethescope is for our own MD reporterm Doctor KSS.
    IRR is for the irregulars for some reason meaning those of us who pay.
    the magnifying glass I am mystified about also.
    It’s all just semiotics, you know. like what Umberto Eco is is prof of.

  4. techscan says:

    My guess is the magnifying glass is SG’s avatar, stethoscope is Dr KSS avatar, the feather indicates an GS contributor, IRR means the comment is from an irregular. You have no avatar since you haven’t added on to your profile. I think I’ll add one to mine later.

    And… Yup… No way to ‘subscribe’!

  5. rhoffer says:

    Perhaps you can answer the Addison Wiggins The last Legal Currency Loophole in America: The Secret 228% Plus Return. Thanks,
    Robin

  6. danielj1960 says:

    Operating Margin (ttm): -555.76% . Does that number scare any of you ? I am not even close to being a hedge fund manager,but that is not the only negative number I am seeing checking out the key statistics on Yahoo finance. I guess Mr Klarmann knows something that we don’t know or is he just trying to squeeze all the short positions ?

  7. eugene11803 says:

    Most biotechs do not have good news at FDA trials. Even the good news often is bad news to the market. Instead of investing $2000, use the $ to take a cruise. In a week you will feel a lot better and have forgotten about the stock.

  8. daljdali says:

    I quick question for Dr. KSS, Please can you add Tapimmune to your long list of companies to review? I bought shares quite some time ago based on a newsletter recommendation. They seem to have good science and a promising pipeline. But hey what do I know? I would appreciate your thoughts on the pipeline. Many thanks,
    Dal

  9. leadmeleadu says:

    I was very happy since beginning of July with the recommendations of BioScience Millionaire and I can go that far to promote his service… All the picks that he suggested had successful results. Unfortunately ACRX failed and dropped by 42% causing big loss for me. But the day before he came up with another pick which looks like promising. This is after the SG the best idea site for me…. But I understood clearly FDA/FDUA play is a gamble. But to me the KERX play is the most interesting one which will happen on 7th . Instead of sending a CRL the committee delayed the approval to 7th Sept, I think they want to approve it.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.